Left ventricular assist device implantation in advanced kidney disease
Although early postoperative mortality is higher, patients with advanced CKD undergoing HeartMate 3 LVAD implantation achieve comparable 1- and 2-year survival to controls. These findings suggest LVAD implantation may be a reasonable option in carefully selected patients with advanced kidney disease.
Authors
- Kris Wittersheim
- Mani A. Daneshmand (ORCID: https://orcid.org/0000-0002-0191-9911)
- Divya Gupta (ORCID: https://orcid.org/0000-0002-9879-8553)
- Benjamin French (ORCID: https://orcid.org/0000-0003-4352-1837)
- J. David Vega
- Anudeep S. Nakirikanti
- Ian M. Kusher
Institutions
- Emory Healthcare (US)
- Emory University (US)
- Emory University Hospital (US)
Publication Details
- Journal
- JHLT Open
- Published
- 2025-10-29
- DOI
- https://doi.org/10.1016/j.jhlto.2025.100422
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.00